1) TRAIL/Apo2L
肿瘤坏死因子相关凋亡诱导配体/凋亡素2配体
2) TRAILR
肿瘤坏死因子相关凋亡诱导配体受体
1.
Objective To investigate the expression of TNF-related apoptosis-inducing ligand(TRAIL) and TNF-related apoptosis-inducing ligand receptor(TRAILR) in thyroid carcinoma.
目的 研究肿瘤坏死因子相关凋亡诱导配体 (TRAIL)和肿瘤坏死因子相关凋亡诱导配体受体(TRAILR)在甲状腺癌中的表达及意义。
4) Tumor necrosis factor related apoptosis induing ligand gene
肿瘤坏死因子相关凋亡诱导配体基因
5) Tumor necrosis factor-related apoptosis inducing ligand
肿瘤坏死因子相关凋亡诱导配体
1.
Expression of tumor necrosis factor-related apoptosis inducing ligand and its receptors in muscle tissues of experimental autoimmune myositis animal model;
特发性炎性肌病动物模型中肿瘤坏死因子相关凋亡诱导配体及其受体的表达
2.
BACKGROUND & OBJECTIVE: Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) can induce apoptosis in various cancer cell lines with little toxicity toward normal cells.
背景与目的:肿瘤坏死因子相关凋亡诱导配体(tumornecrosisfactor-relatedapoptosisinducingligand,TRAIL)有广谱的抗瘤作用,且对正常组织细胞无毒性,因此有望应用于肿瘤基因治疗。
6) tumor necrosis factor-related apoptosis-inducing ligand
肿瘤坏死因子相关凋亡诱导配体
1.
Objective:To explore the anti-tumor effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) against giant cell tumor of bone (GCT), and to study the influence of IFN-γ on the anti-tumor effects of TRAIL and the possible mechanisms.
目的:探讨肿瘤坏死因子相关凋亡诱导配体(tumor necrosis factor-related apoptosis-inducing ligand,TRAIL)对人骨巨细胞瘤(giant cell tumor of bone,GCT)的作用及干扰素-γ(interferon-γ,IFN-γ)对TRAIL抗瘤活性的影响,并探讨其影响机制。
2.
Objective:To observe the effects of different concentrations of glucose on the expression of tumor necrosis factor-related apoptosis-inducing ligand(TRAIL),osteoprotegerin(OPG),and the ligand of osteoprotegerin(OPGL)in osteosarcoma MG63 cells,so as to assess the role of glucose in pathogenesis of diabetic osteoporosis.
目的:观察在不同浓度葡萄糖环境下人成骨肉瘤MG63细胞株肿瘤坏死因子相关凋亡诱导配体(TRAIL)及其护骨素(OPG)、护骨素配体(OPGL)的表达,探讨糖尿病骨质疏松症的发病机制。
3.
Aim: To investigate the relationship between the expression of tumor necrosis factor-related apoptosis-inducing ligand(TRAIL),cell proliferation and apoptosis in children′s skin hemangioma.
目的探讨小儿皮肤血管瘤各阶段肿瘤坏死因子相关凋亡诱导配体(TRAIL)的表达与细胞增殖和凋亡的关系。
补充资料：亡阳证
| 亡阳证 人体阳气亡失的危重证候。见于各种疾病的危重阶段。一般在高热大汗，或发汗太过，或吐泻过度，失血过多的情况下，导致阳气突然衰竭，特别是大汗容易导致亡阴与亡阳。慢性消耗性疾病的亡阳，多由于阳气的严重耗散，虚阳外越所致。亡阳证的临床表现为大汗淋漓，汗出如珠，畏寒蜷卧，四肢厥冷，精神萎靡，面色苍白，呼吸微弱，渴喜热饮，舌淡苔白，脉微细欲绝，或浮数而空。亡阳证较亡阴证在危急程度上更进一步，危在旦夕，急当救治。治宜回阳固脱，方用独参汤、参附汤、回阳还本汤等。 |
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条